Specialist Registrar / Clinical Research Fellow
Leeds Teaching Hospitals NHS Trust / University of Leeds
Peter qualified in Medicine at the University of Edinburgh in 2003. After general clinical training he was appointed as Specialist Registrar in Medical Oncology in 2006 on the Yorkshire rotation, based at St James Institute of Oncology in Leeds. In 2008 he was awarded a Clinical Research Fellowship with the University of Leeds Clinical Trials Research Unit and also joined the Academic Unit of Health Economics at the University of Leeds as Associate Research Fellow.
His research interest is in the design and analysis of clinical trials which aim to inform pragmatic evidence based decision making for patients in the NHS, with a focus on cancer treatments. His research includes the use of Bayesian decision modelling early in drug development to inform later phase clinical trial designs. He is interested in all aspects of cancer treatment but his clinical trials research focuses on drug treatments for early breast cancer and the optimal management of frail or elderly patients with advanced gastric and oesophageal cancer.
Clinical research for new cancer drugs is predominantly designed to inform the decision to grant a drug license. Peter's work with NICE aims to identify and define the specific evidence requirements of reimbursement decision makers such as NICE. The objective is to make recommendations to clinical researchers on the design of research into new cancer drugs, maximising its ability to inform reimbursement decisions, not just licensing decisions, and measure their true value to patients and the NHS.
This page was last updated: 25 March 2011